search
Back to results

Evidence Based Information Provision to Improve Decision Making After Oesophagogastric Cancer Diagnosis (SOURCE) (SOURCE)

Primary Purpose

Oesophageal Cancer, Gastric Cancer

Status
Recruiting
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Tool and training
Sponsored by
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Oesophageal Cancer focused on measuring Prediction models, Tailored information, Stepped Wedge Trial, Oesophageal cancer, Gastric cancer, Webtool, Health care provider training

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

Health care providers:

  • Specialist, physician assistant or nurse practitioner in the field of oncology, oncological radiotherapy or oncological surgery who are used to discussing treatment and treatment outcome with patients
  • Informed consent for data collection
  • Three audiorecorded treatment information consultations with oesophageal or gastric cancer patients before the scheduled transition period (control measurements)
  • Three audiorecorded treatment information consultations with oesophageal or gastric cancer patients after the scheduled transition period (intervention measurements) and before the scheduled end date of the study

Patients:

  • Age ≥ 18 years
  • Histological or cytological proof of oesophageal or gastric cancer
  • Informed consent for trial data collection A treatment information consultation with a participating doctor to discuss either curative treatment, first line palliative treatment, and/or best supportive care.

Exclusion Criteria:

Health care providers:

- Less than two control and/or intervention measurements

Patients:

  • Cognitive impairment or insufficient understanding of the Dutch language
  • GIST and smallcell carcinomas.

Sites / Locations

  • Academic Medical CenterRecruiting
  • FlevoziekenhuisRecruiting
  • VUmcRecruiting
  • Radiotherapiegroep
  • Rijnstate
  • Catherina Ziekenhuis
  • LUMC
  • Maastro
  • Radboud UMC
  • BVI
  • ETZ
  • UMC Utrecht

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Intervention

Arm Description

The Source tool is used by care givers for informing patients about the outcomes of treatment. Prediction models are developed and built in the website in order to generate a personalized prediction of the outcomes: survival, toxicity and/or complications and HRQL. These predictions are visualized in clear and comprehensible graphs with a broad variation of options available for tailoring of the visualizations. In order for care givers to be able to use this tool effectively, we designed the Source training. This communication skills training is comprised of an e-learning, two face-to-face group sessions and an individual booster session. Aside from an instruction video on the navigation within the Source tool, the e-learning consists of theory and tips and tricks on how to inform patients and communicate risks. The face-to-face components of the training are focused on getting the skilled use of the source tool into practice, by receiving personal feedback on the performance.

Outcomes

Primary Outcome Measures

SOURCE observational scale
The SOURCE observational scale is developed to primary answer the following question: Does the combination of the tool and the training improve observed (numerical) precision of information about treatment outcomes in clinical consultations? Min. value: 1 Max. value:4 Higher scores mean higher (numerical) precision

Secondary Outcome Measures

Continuing professional development (CPD) reaction Questionnaire
Health care providers' intention to inform patients about treatment outcomes using numbers (effect training only)
Patient Satisfaction Questionnaire (PSQ-5 patient and doctor version)
Patient and physician satisfaction with communication and decision making
Shared Decision Making Questionnaire (SDMQ-9)
Patient-reported shared decision making
Decisional Conflict Scale (DCS)
Patients' evaluation of the decision made
EORTC QLQ - INFO25 + tailor made items on treatment outcome information
Patients' evaluation and knowledge of the information provided by the health care provider
EORTC QLQ-C30
Patients' health related quality of life, cancer specific
EORTC QLQ-OG25
Patients' health related quality of life, gastro-intestinal cancer specific
Trust in the Oncologist Scale (TiOS-sf)
Patients' trust in the health care provider
State-Trait Anxiety Inventory (STAI)
Patients' anxiety
((Mini-)Mental Adjustment to Cancer scale ((Mini-)MAC)
Patients' helplessness/hopelessness + fighting spirit
Duration of consultation in minutes (min.)
Consultation time
Health care providers' personalization of treatment outcome information measured with SOURCE observational scale
Frequency of explicitly personalizing treatment outcome information, based on audio tapes Min. value: 0 Max. value: endless Higher values mean more utterances of personalization
Health care providers' tailoring of treatment outcome information measured with SOURCE observational scale
Frequency of explicitly tailoring treatment outcome information, based on audio tapes Min. value: 0 Max. value: endless Higher values mean more utterances of tailoring
Health care providers' use of visualizations of treatment outcome information measured with SOURCE observational scale
Frequency of explicitly showing visualizations treatment outcome information, based on audio tapes Min. value: 0 Max. value: endless Higher values mean more utterances of showing visualizations
Health care providers' use of time frames when giving treatment outcome information measured with SOURCE observational scale
Presence of time frame when giving treatment outcome information, in utterances coded for the primary outcome Min. value: 0 Max. value: 1 Value 1 means time frame present, value 0 means time frame absent
Treatment outcome category of health care providers' treatment outcome information measured with SOURCE observational scale
Treatment outcome category of health care providers' treatment outcome information, in utterances coded for the primary outcome Values: Survival, Health-related Quality of Life, Side effects and complications, Progression of tumor Non-ordinal variable
Person initializing treatment outcome information measured with SOURCE observational scale
Person taking the initaitive for the health care provider's treatment outcome information, in utterances coded for the primary outcome Values: Health care provider, Patient Non-ordinal variable
Health care providers' (numerical) precision of treatment outcome information measured with SOURCE observational scale simulated patient consultations (effect intervention)
Health care providers' (numerical) precision of treatment outcome information measured in simulated patient consultations (effect intervention) Min. value: 1 Max. value:4 Higher scores mean higher (numerical) precision

Full Information

First Posted
December 20, 2019
Last Updated
December 15, 2022
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Collaborators
Dutch Cancer Society
search

1. Study Identification

Unique Protocol Identification Number
NCT04232735
Brief Title
Evidence Based Information Provision to Improve Decision Making After Oesophagogastric Cancer Diagnosis (SOURCE)
Acronym
SOURCE
Official Title
Stimulating Evidence Based, Personalized and Tailored Information Provision to Improve Decision Making After Oesophagogastric CancEr Diagnosis - a Pragmatic Stepped Wedge Trial-
Study Type
Interventional

2. Study Status

Record Verification Date
December 2022
Overall Recruitment Status
Recruiting
Study Start Date
October 13, 2020 (Actual)
Primary Completion Date
September 30, 2023 (Anticipated)
Study Completion Date
September 30, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Collaborators
Dutch Cancer Society

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The overarching aim of the programme 'Stimulating evidence based, personalized and tailored information provision to improve decision making after oesophagogastric cancer diagnosis' (SOURCE) is to provide oesophagogastric cancer patients at all disease stages with evidence based and personalized information about survival, treatment-related side-effects and/or complications and health related quality of life, tailored to patients' specific information needs, to facilitate informed decision making about treatment and thereby optimize personal care and outcomes. For this purpose the Source tool and training were designed. The Source tool is a prediction model based website to be used by care givers for informing patients about the outcomes of treatment. The Source training for care givers is designed to learn care givers how to inform patients effectively, especially about the outcomes of treatment.
Detailed Description
The overarching aim of the programme 'Stimulating evidence based, personalized and tailored information provision to improve decision making after oesophagogastric cancer diagnosis' (SOURCE) is to provide oesophagogastric cancer patients at all disease stages with evidence based and personalized information about survival, treatment-related side-effects and/or complications and health related quality of life, tailored to patients' specific information needs, to facilitate informed decision making about treatment and thereby optimize personal care and outcomes. For this purpose the Source tool and training were designed. The Source tool is a prediction model based website to be used by care givers for informing patients about the outcomes of treatment. The Source training for care givers is designed to learn care givers how to inform patients effectively, especially about the outcomes of treatment. The primary aim of the SOURCE trial is to investigate the effect of the tool and training on the (numerical) precision of information about outcomes of treatment in the treatment information consultation. Secondary outcomes include: patients' satisfaction, evaluation and knowledge of the information provided by the health care provider, evaluation of the decision made and health related quality of life. A pragmatic stepped wedge design will be used to test the effect of intervention. 21 health care providers will include 3 patients as control measurements (before intervention) and 3 patients as intervention measurements (after intervention). Participating centers will be divided into geographical subgroups, in which the transition period (in which the intervention will take place) will be spread across time. All oesophageal and gastric cancer patients scheduled for a treatment information consultation with a participating health care provider are suitable for inclusion and will be approached for participation in the SOURCE study. Measurements include audio recordings of the treatment information consultation and questionnaires filled in by patients and health care providers at different moments in time. Audio recordings will be scored and analyzed based on a study specific coding scheme. The investigators estimate the physical burden/risk of this study to be negligible.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Oesophageal Cancer, Gastric Cancer
Keywords
Prediction models, Tailored information, Stepped Wedge Trial, Oesophageal cancer, Gastric cancer, Webtool, Health care provider training

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Pragmatic Stepped Wedge Design
Masking
None (Open Label)
Allocation
N/A
Enrollment
126 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention
Arm Type
Experimental
Arm Description
The Source tool is used by care givers for informing patients about the outcomes of treatment. Prediction models are developed and built in the website in order to generate a personalized prediction of the outcomes: survival, toxicity and/or complications and HRQL. These predictions are visualized in clear and comprehensible graphs with a broad variation of options available for tailoring of the visualizations. In order for care givers to be able to use this tool effectively, we designed the Source training. This communication skills training is comprised of an e-learning, two face-to-face group sessions and an individual booster session. Aside from an instruction video on the navigation within the Source tool, the e-learning consists of theory and tips and tricks on how to inform patients and communicate risks. The face-to-face components of the training are focused on getting the skilled use of the source tool into practice, by receiving personal feedback on the performance.
Intervention Type
Other
Intervention Name(s)
Tool and training
Intervention Description
The Source tool aims to assist health care providers with giving evidence based information about treatment outcomes by providing visualizations of personalized predictions of treatment outcomes for different treatments of oesophageal and gastric cancer. These predictions result from recently designed and updated prediction models on the survival, toxicity, complications and health related quality of life of oesophageal and gastric cancer patients. The training aims to teach participants to inform patients about outcomes of treatment. The training is placed in the context of shared decision making (SDM), following the 4-step model by Stiggelbout et al., 2015.8 The training is provided in small groups (3-6 participants) by an experienced trainer and supported by professional actors. The training aims to address knowledge, attitude and skills.
Primary Outcome Measure Information:
Title
SOURCE observational scale
Description
The SOURCE observational scale is developed to primary answer the following question: Does the combination of the tool and the training improve observed (numerical) precision of information about treatment outcomes in clinical consultations? Min. value: 1 Max. value:4 Higher scores mean higher (numerical) precision
Time Frame
through study completion, an average of 1 year
Secondary Outcome Measure Information:
Title
Continuing professional development (CPD) reaction Questionnaire
Description
Health care providers' intention to inform patients about treatment outcomes using numbers (effect training only)
Time Frame
through study completion, an average of 1 year
Title
Patient Satisfaction Questionnaire (PSQ-5 patient and doctor version)
Description
Patient and physician satisfaction with communication and decision making
Time Frame
2 weeks
Title
Shared Decision Making Questionnaire (SDMQ-9)
Description
Patient-reported shared decision making
Time Frame
2 weeks
Title
Decisional Conflict Scale (DCS)
Description
Patients' evaluation of the decision made
Time Frame
2 weeks
Title
EORTC QLQ - INFO25 + tailor made items on treatment outcome information
Description
Patients' evaluation and knowledge of the information provided by the health care provider
Time Frame
2 weeks
Title
EORTC QLQ-C30
Description
Patients' health related quality of life, cancer specific
Time Frame
3 months vs. baseline
Title
EORTC QLQ-OG25
Description
Patients' health related quality of life, gastro-intestinal cancer specific
Time Frame
3 months vs. baseline
Title
Trust in the Oncologist Scale (TiOS-sf)
Description
Patients' trust in the health care provider
Time Frame
2 weeks
Title
State-Trait Anxiety Inventory (STAI)
Description
Patients' anxiety
Time Frame
2 weeks vs. baseline
Title
((Mini-)Mental Adjustment to Cancer scale ((Mini-)MAC)
Description
Patients' helplessness/hopelessness + fighting spirit
Time Frame
2 weeks vs. baseline
Title
Duration of consultation in minutes (min.)
Description
Consultation time
Time Frame
through study completion, an average of 1 year
Title
Health care providers' personalization of treatment outcome information measured with SOURCE observational scale
Description
Frequency of explicitly personalizing treatment outcome information, based on audio tapes Min. value: 0 Max. value: endless Higher values mean more utterances of personalization
Time Frame
through study completion, an average of 1 year
Title
Health care providers' tailoring of treatment outcome information measured with SOURCE observational scale
Description
Frequency of explicitly tailoring treatment outcome information, based on audio tapes Min. value: 0 Max. value: endless Higher values mean more utterances of tailoring
Time Frame
through study completion, an average of 1 year
Title
Health care providers' use of visualizations of treatment outcome information measured with SOURCE observational scale
Description
Frequency of explicitly showing visualizations treatment outcome information, based on audio tapes Min. value: 0 Max. value: endless Higher values mean more utterances of showing visualizations
Time Frame
through study completion, an average of 1 year
Title
Health care providers' use of time frames when giving treatment outcome information measured with SOURCE observational scale
Description
Presence of time frame when giving treatment outcome information, in utterances coded for the primary outcome Min. value: 0 Max. value: 1 Value 1 means time frame present, value 0 means time frame absent
Time Frame
through study completion, an average of 1 year
Title
Treatment outcome category of health care providers' treatment outcome information measured with SOURCE observational scale
Description
Treatment outcome category of health care providers' treatment outcome information, in utterances coded for the primary outcome Values: Survival, Health-related Quality of Life, Side effects and complications, Progression of tumor Non-ordinal variable
Time Frame
through study completion, an average of 1 year
Title
Person initializing treatment outcome information measured with SOURCE observational scale
Description
Person taking the initaitive for the health care provider's treatment outcome information, in utterances coded for the primary outcome Values: Health care provider, Patient Non-ordinal variable
Time Frame
through study completion, an average of 1 year
Title
Health care providers' (numerical) precision of treatment outcome information measured with SOURCE observational scale simulated patient consultations (effect intervention)
Description
Health care providers' (numerical) precision of treatment outcome information measured in simulated patient consultations (effect intervention) Min. value: 1 Max. value:4 Higher scores mean higher (numerical) precision
Time Frame
through study completion, an average of 1 year
Other Pre-specified Outcome Measures:
Title
Observed presence of Source tool measured with SOURCE observational scale
Description
Health care providers' observed use of the Source tool Min. value: 0 Max. value:1 Value 0 means absence of Source tool in consultation, Value 1 means presence of Source tool in conversation
Time Frame
through study completion, an average of 1 year
Title
SOURCE evaluation questionnaire (tailor made evaluation questionnaire)
Description
Health care providers' evaluation of the Source tool, training and e-learning Min value: 1 Max value: 10 Higher scores mean better evaluations
Time Frame
through study completion, an average of 1 year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Health care providers: Specialist, physician assistant or nurse practitioner in the field of oncology, oncological radiotherapy or oncological surgery who are used to discussing treatment and treatment outcome with patients Informed consent for data collection Three audiorecorded treatment information consultations with oesophageal or gastric cancer patients before the scheduled transition period (control measurements) Three audiorecorded treatment information consultations with oesophageal or gastric cancer patients after the scheduled transition period (intervention measurements) and before the scheduled end date of the study Patients: Age ≥ 18 years Histological or cytological proof of oesophageal or gastric cancer Informed consent for trial data collection A treatment information consultation with a participating doctor to discuss either curative treatment, first line palliative treatment, and/or best supportive care. Exclusion Criteria: Health care providers: - Less than two control and/or intervention measurements Patients: Cognitive impairment or insufficient understanding of the Dutch language GIST and smallcell carcinomas.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Loïs F. van de Water, MSc.
Phone
020-5665955
Email
l.f.vandewater@amsterdamumc.nl
First Name & Middle Initial & Last Name or Official Title & Degree
Hanneke WM van Laarhoven, Prof. Dr.
Phone
020-5665955
Email
hvanlaarhoven@amsterdamumc.nl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
H WM van Laarhoven, Prof. Dr.
Organizational Affiliation
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Official's Role
Principal Investigator
Facility Information:
Facility Name
Academic Medical Center
City
Amsterdam
State/Province
Noord Holland
ZIP/Postal Code
1105AZ
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Loïs F van de Water, MSc.
Phone
+31205665955
Email
l.f.vandewater@amsterdamumc.nl
First Name & Middle Initial & Last Name & Degree
Hanneke WM van Laarhoven, MD, PhD
Facility Name
Flevoziekenhuis
City
Almere
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Loïs F van de Water, MSc.
Facility Name
VUmc
City
Amsterdam
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Loïs F van de Water, MSc.
Facility Name
Radiotherapiegroep
City
Arnhem
Country
Netherlands
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Loïs F van de Water, MSc.
Facility Name
Rijnstate
City
Arnhem
Country
Netherlands
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Loïs F van de Water, MSc.
Facility Name
Catherina Ziekenhuis
City
Eindhoven
Country
Netherlands
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Loïs F van de Water, MSc.
Facility Name
LUMC
City
Leiden
Country
Netherlands
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Loïs F. van de Water, MSc.
Facility Name
Maastro
City
Maastricht
Country
Netherlands
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Loïs F van de Water, MSc.
Facility Name
Radboud UMC
City
Nijmegen
Country
Netherlands
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Loïs F van de Water, MSc.
Facility Name
BVI
City
Tilburg
Country
Netherlands
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Loïs F van de Water, MSc.
Facility Name
ETZ
City
Tilburg
Country
Netherlands
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Loïs F van de Water, MSc.
Facility Name
UMC Utrecht
City
Utrecht
Country
Netherlands
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Loïs F. van de Water, MSc.

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Evidence Based Information Provision to Improve Decision Making After Oesophagogastric Cancer Diagnosis (SOURCE)

We'll reach out to this number within 24 hrs